Edwards Lifesciences Cash Flow from Financial Activities 2010-2025 | EW
Edwards Lifesciences annual/quarterly cash flow from financial activities history and growth rate from 2010 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- Edwards Lifesciences cash flow from financial activities for the quarter ending March 31, 2025 was $-0.258B, a 518.15% decline year-over-year.
- Edwards Lifesciences cash flow from financial activities for the twelve months ending March 31, 2025 was $-2.288B, a 107.65% increase year-over-year.
- Edwards Lifesciences annual cash flow from financial activities for 2024 was $-0.983B, a 38.26% increase from 2023.
- Edwards Lifesciences annual cash flow from financial activities for 2023 was $-0.711B, a 55.13% decline from 2022.
- Edwards Lifesciences annual cash flow from financial activities for 2022 was $-1.585B, a 344.71% increase from 2021.
| Edwards Lifesciences Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $-983 |
| 2023 | $-711 |
| 2022 | $-1,585 |
| 2021 | $-356 |
| 2020 | $-487 |
| 2019 | $-116 |
| 2018 | $-1,101 |
| 2017 | $-473 |
| 2016 | $-269 |
| 2015 | $-159 |
| 2014 | $-153 |
| 2013 | $35 |
| 2012 | $-156 |
| 2011 | $-135 |
| 2010 | $-104 |
| 2009 | $-92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.869B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.883B | 81.42 |
| Thermo Fisher Scientific (TMO) | United States | $156.566B | 18.94 |
| Alcon (ALC) | Switzerland | $43.085B | 29.12 |
| IDEXX Laboratories (IDXX) | United States | $41.386B | 47.56 |
| DexCom (DXCM) | United States | $32.894B | 50.84 |
| IQVIA Holdings (IQV) | United States | $27.789B | 15.56 |
| Mettler-Toledo (MTD) | United States | $24.833B | 29.53 |
| STERIS (STE) | Ireland | $22.191B | 24.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.420B | 0.00 |
| Waters (WAT) | United States | $17.111B | 24.14 |
| Hologic (HOLX) | United States | $14.260B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.443B | 29.62 |
| Penumbra (PEN) | United States | $8.922B | 70.02 |
| Masimo (MASI) | United States | $8.375B | 30.89 |
| Globus Medical (GMED) | United States | $7.627B | 18.17 |
| Glaukos (GKOS) | United States | $5.583B | 0.00 |
| Teleflex (TFX) | United States | $4.908B | 8.10 |
| Integer Holdings (ITGR) | United States | $3.925B | 20.56 |
| TransMedics (TMDX) | United States | $3.717B | 80.79 |
| PROCEPT BioRobotics (PRCT) | United States | $3.228B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.289B | 13.63 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Nihon Kohden (NHNKY) | Japan | $1.863B | 21.37 |
| Veracyte (VCYT) | United States | $1.841B | 25.84 |
| Alphatec Holdings (ATEC) | United States | $1.533B | 0.00 |
| Artivion (AORT) | United States | $1.302B | 121.96 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.984B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.865B | 4.60 |
| IRadimed (IRMD) | United States | $0.721B | 36.57 |
| SiBone (SIBN) | United States | $0.708B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.589B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.564B | 12.24 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.519B | 8.07 |
| AxoGen (AXGN) | United States | $0.514B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.416B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.411B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.385B | 8.96 |
| Treace Medical Concepts (TMCI) | United States | $0.355B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.309B | 0.00 |
| RxSight (RXST) | United States | $0.299B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.242B | 0.00 |
| 908 Devices (MASS) | United States | $0.240B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.221B | 13.41 |
| CVRx (CVRX) | United States | $0.209B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.110B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.40 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.17 |